| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Yue-Rong Liang | Q87461889 |
| P2093 | author name string | Rui Yang | |
| Jian-Hui Ye | |||
| Jian-Liang Lu | |||
| Qing-Sheng Li | |||
| Xin-Qiang Zheng | |||
| Meng Shi | |||
| Xu-Min Li | |||
| Zhuo-Yu Cai | |||
| Yun-Long Shi | |||
| Shi-Cheng Ma | |||
| P2860 | cites work | Suppressive Effects of Tea Catechins on Breast Cancer | Q26739963 |
| Tea Polysaccharides and Their Bioactivities | Q28079038 | ||
| Reaction kinetics of degradation and epimerization of epigallocatechin gallate (EGCG) in aqueous system over a wide temperature range | Q28273749 | ||
| Ultraviolet B (UVB) Photosensitivities of Tea Catechins and the Relevant Chemical Conversions. | Q31136428 | ||
| Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells | Q33762703 | ||
| Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives | Q33990318 | ||
| Bioavailability challenges associated with development of anti-cancer phenolics | Q34057398 | ||
| Influence of processing on functionality of milk and dairy proteins. | Q34694662 | ||
| Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions | Q35066981 | ||
| Anticarcinogenic effects of (-)-epigallocatechin gallate | Q35415742 | ||
| Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer | Q36691608 | ||
| Natural and synthetic polymers as inhibitors of drug efflux pumps | Q36951710 | ||
| Bioavailability issues in studying the health effects of plant polyphenolic compounds | Q37190552 | ||
| Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-κB-mediated mechanism | Q37276839 | ||
| Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation. | Q37395602 | ||
| Microencapsulation as a tool for incorporating bioactive ingredients into food. | Q37812353 | ||
| Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries. | Q38177928 | ||
| Food-grade micro-encapsulation systems that may induce satiety via delayed lipolysis: A review. | Q38562451 | ||
| Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. | Q38768038 | ||
| Binding of tea catechins to rice bran protein isolate: Interaction and protective effect during in vitro digestion | Q38909766 | ||
| Camellia sinensis L. Extract and Its Potential Beneficial Effects in Antioxidant, Anti-Inflammatory, Anti-Hepatotoxic, and Anti-Tyrosinase Activities. | Q38920452 | ||
| Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems | Q38988177 | ||
| Recent Advances in Anticancer Activities and Drug Delivery Systems of Tannins | Q39048429 | ||
| Antidiabetic Effects of Tea. | Q39322313 | ||
| Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. | Q39616510 | ||
| Layer-by-Layer-Coated Gelatin Nanoparticles as a Vehicle for Delivery of Natural Polyphenols | Q39836903 | ||
| Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas | Q40327677 | ||
| Stability of tea polyphenol (-)-epigallocatechin-3-gallate and formation of dimers and epimers under common experimental conditions | Q40370729 | ||
| Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues | Q40383786 | ||
| Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. | Q40631215 | ||
| Stability of Polyphenols Epigallocatechin Gallate and Pentagalloyl Glucose in a Simulated Digestive System | Q42082283 | ||
| Intestinal efflux transport kinetics of green tea catechins in Caco-2 monolayer model | Q42509026 | ||
| Encapsulation of epigallocatechin-3-gallate (EGCG) using oil-in-water (O/W) submicrometer emulsions stabilized by ι-carrageenan and β-lactoglobulin | Q42906824 | ||
| Plasma appearance and correlation between coffee and green tea metabolites in human subjects | Q42944178 | ||
| Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate | Q42987462 | ||
| Inhibitory effects of plant phenols on the activity of selected enzymes | Q44008502 | ||
| Antiinflammatory action of EGCG, the main component of green tea, through STAT-1 inhibition | Q44251714 | ||
| Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells | Q44260419 | ||
| Epimerization of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate: relationship between epimerization and chemical structure. | Q44271692 | ||
| Assembly of bioactive peptide-chitosan nanocomplexes | Q44472050 | ||
| Epigallocatechin gallate effectively ameliorates fluoride-induced oxidative stress and DNA damage in the liver of rats | Q45115701 | ||
| TEAVIGO (epigallocatechin gallate) supplementation prevents obesity in rodents by reducing adipose tissue mass | Q45285862 | ||
| (-)-Epigallocatechin gallate/gelatin layer-by-layer assembled films and microcapsules | Q46232721 | ||
| Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions | Q46260399 | ||
| Presence or absence of a gallate moiety on catechins affects their cellular transport | Q46418372 | ||
| Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro | Q46506966 | ||
| Stability of chitosan nanoparticles for L-ascorbic acid during heat treatment in aqueous solution | Q46745919 | ||
| Effect of the co-occurring components from green tea on the intestinal absorption and disposition of green tea polyphenols in Caco-2 monolayer model | Q46879744 | ||
| pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles | Q47870387 | ||
| Urea-Driven Epigallocatechin Gallate (EGCG) Permeation into the Ferritin Cage, an Innovative Method for Fabrication of Protein-Polyphenol Co-assemblies. | Q48278325 | ||
| Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate | Q50195683 | ||
| Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid | Q50443747 | ||
| Delivery of green tea catechin and epigallocatechin gallate in liposomes incorporated into low-fat hard cheese | Q50459425 | ||
| Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (-)-epigallocatechin-3-gallate. | Q50485467 | ||
| Kinetic study of catechin stability: effects of pH, concentration, and temperature. | Q50487244 | ||
| Cellular uptake and cytotoxicity of chitosan-caseinophosphopeptides nanocomplexes loaded with epigallocatechin gallate. | Q50495056 | ||
| Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability. | Q50511907 | ||
| Development of (-)-epigallocatechin-3-gallate (EGCG)-loaded enteric microparticles with intestinal mucoadhesive property. | Q50524695 | ||
| Common tea formulations modulate in vitro digestive recovery of green tea catechins. | Q50670325 | ||
| Encapsulation of epigallocatechin gallate in zein/chitosan nanoparticles for controlled applications in food systems. | Q51031547 | ||
| Encapsulation of (-)-epigallocatechin gallate into liposomes and into alginate or chitosan microparticles reinforced with liposomes. | Q51488456 | ||
| Kinetic study of the thermal stability of tea catechins in aqueous systems using a microwave reactor. | Q51936278 | ||
| Differential behaviors of tea catechins under thermal processing: Formation of non-enzymatic oligomers. | Q53654864 | ||
| Tandem mass spectrometry studies of green tea catechins. Identification of three minor components in the polyphenolic extract of green tea | Q74140400 | ||
| Antioxidant chemistry of green tea catechins. Identification of products of the reaction of (-)-epigallocatechin gallate with peroxyl radicals | Q77336610 | ||
| Mechanistic studies of catechins as antioxidants against radical oxidation | Q77901335 | ||
| Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability | Q83299867 | ||
| The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles | Q83725870 | ||
| Antioxidant Nanocomplexes for Delivery of Epigallocatechin-3-gallate | Q89158569 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | compounding | Q1303150 |
| P577 | publication date | 2018-02-17 | |
| P1433 | published in | Molecules | Q151332 |
| P1476 | title | Food-grade Encapsulation Systems for (-)-Epigallocatechin Gallate | |
| P478 | volume | 23 |
| Q55318247 | Association of Tea Consumption with Risk of Alzheimer's Disease and Anti-Beta-Amyloid Effects of Tea. |
| Q58696704 | Bioavailability of Tea Catechins and Its Improvement |
| Q64268357 | Catechin in Human Health and Disease |
| Q64113697 | Effects of Epigallocatechin Gallate on the Stability of Epicatechin in a Photolytic Process |
| Q93080090 | Electrospray-Based Microencapsulation of Epigallocatechin 3-Gallate for Local Delivery into the Intervertebral Disc |
| Q93054853 | Nanodelivery of Natural Antioxidants: An Anti-aging Perspective |
| Q61813468 | Tea Polyphenols in Promotion of Human Health |
Search more.